Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single dose, "block-replace" drug therapy in hyperthyroidism.

P H Wise, M Marion, R W Pain

    British Medical Journal
    |October 20, 1973
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum to "Involvement of mitochondrial and death receptor pathways in tributyltin-induced apoptosis in rat hepatocytes" [Biochim. Biophys. Acta 1693 (2004) 15-27 (15276321)].

    Biochimica et biophysica acta. Molecular cell research·2026
    Same author

    Diagnostic wandering in hidradenitis suppurativa: A nationwide cohort study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2024
    Same author

    Patient-Specific Modelling of Blood Coagulation.

    Bulletin of mathematical biology·2021
    Same author

    Positive selection of type 2 diabetes genotypes - the glycaemic threshold hypothesis.

    Medical hypotheses·2019
    Same author

    Heterodonty and patterns of tooth replacement in Crocodylus niloticus.

    Journal of morphology·2018
    Same author

    Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

    Genes and immunity·2015
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    This study shows that a combined therapy of carbimazole and triiodothyronine effectively blocks thyroid hormone production in hyperthyroid patients. This treatment offers stable control and is suitable for long-term management, even in remote settings.

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Internal Medicine

    Background:

    • Hyperthyroidism, characterized by an overactive thyroid gland, requires effective management to restore hormonal balance.
    • Diffuse goiter is a common manifestation associated with hyperthyroidism, necessitating therapeutic interventions.
    • Current treatment strategies aim to control excessive thyroid hormone production and its associated symptoms.

    Purpose of the Study:

    • To evaluate the efficacy of a divided dose therapy using carbimazole and triiodothyronine in managing hyperthyroidism.
    • To assess the long-term maintenance of thyroid hormone suppression with this combined regimen.
    • To determine the overall acceptability and practicality of this therapeutic approach in clinical settings.

    Main Methods:

    • Thirty consecutive patients diagnosed with hyperthyroidism and diffuse goiter were enrolled in the study.

    Related Experiment Videos

  • A divided daily dose regimen of carbimazole (40 mg) and triiodothyronine (80 mug) was administered.
  • The ability to maintain a blocked state of thyroid hormonogenesis and achieve euthyroid control was monitored.

    • Main Results:

    • The combined therapy successfully induced a total or subtotal block in thyroid hormone production in all patients.
    • This hormonal block was consistently maintained with a reduced single daily dose for up to three years.
    • Patients exhibited good tolerance to the treatment, with stable euthyroid control achieved.

    Conclusions:

    • Divided dose therapy with carbimazole and triiodothyronine is an effective method for achieving and maintaining thyroid hormone suppression in hyperthyroid patients.
    • The regimen demonstrates high patient acceptability, stable euthyroid control, and ease of monitoring, supporting its wider clinical application.
    • This therapeutic approach is particularly beneficial for managing patients in remote areas due to its practicality and sustained efficacy.